Ozempic Users Win Eye-Disease Payout in Novo’s Home Market
Four patients who developed a serious eye disease after using Novo Nordisk A/S’s blockbuster weight-loss drugs have been…
Lawmakers Press FDA to Target Knockoff Weight-Loss Drugs
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss…